Clopidogrel: Hemorheological effects in subjects with subclinical atherosclerosis

Clinical Hemorheology and Microcirculation

Volumn 25, Issue 1, 2001, Pages 31-39

  Ciuffetti, Giovanni ^a   Lombardini, Rita ^a   Pirro, Matteo ^b   Lupattelli, Graziana ^b   Mannarino, Elmo ^b  

^a Internal Medicine Angiology and Arteriosclerosis Diseases Department   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; TICLOPIDINE;

ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; FEMORAL ARTERY; HUMAN; MALE; PLASMA VISCOSITY; RANDOMIZED CONTROLLED TRIAL; SHEAR RATE; TREATMENT OUTCOME;

ADULT; ARTERIOSCLEROSIS; BLOOD CELL COUNT; BLOOD VISCOSITY; DOUBLE-BLIND METHOD; ERYTHROCYTE INDICES; FEMALE; FIBRINOGEN; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0035666930     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. A.M. Ehrly and H.J. Kohler, Altered deformability of erythrocytes from patients with chronic occlusive arterial disease, Kara 5 (1976), 319-322.
2. B. Isomaa, H. Hagerstrand, G. Paatero and A.C. Engblom, Permeability alterations and antihaemolysis is induced by amphiphiles in human erythrocytes, Biochim. Biophys. Acta 860 (1986), 510-524.
3. B. Jarvis and K. Simpson, Clopidogrel: a review of its use in the prevention of atherothrombosis, Drugs 60 (2000), 347-377.
4. D. Mills, R. Puri, C. Hu, C. Minitti, G. Grana, M.D. Freedman, R.F. Colman and R.W. Colman, Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase, Arterioscler. Thromb. 12 (1992), 430-436.
5. G.B. Nash, J.K. Jones, J. Mikita, B. Christopher and J.A. Dormandy, Effects of preparative procedures and of cell activation on flow of white cells through micropore filters, Br. J. Haematol. 70 (1988), 171-176.
6. G. Caimi, R. Lo Presti, A. Serra, G. Francavilla, A. Catania and A. Sarno, Red cell filterability and erytrhrocyte membrane microviscosity during ticlopidine treatment, J. Int. Med. Res. 18 (1990), 161-163.
7. G.D.O. Lowe, Evaluation of Theological therapy by orally administred drugs, Clin. Hemorheol. 4 (1984), 159-175.
8. G.D.O. Lowe, Blood rheology in general medicine and surgery, Bailliere's Clin. Haematol. 1 (1987), 827-861.
9. G. Hollopeter, H.M. Jantzen, D. Vincent, G. Li, L. England, V. Ramakrishnan, R.B. Yang, P. Nurden, A. Nurden, D. Julius and P.B. Conley, Identification of the platelet ADP receptor targeted by antithrombotic drugs, Nature 11 (2001), 202-207.
10. G. Mancini, A.D. Carbonara and J.F. Haremans, Immunochemical quantitation of antigens by single radial immunodiffusion, Immunochemistry 2 (1965), 235-240.
11. H. Solvay, M. Kahn, S. Garreyn, M. Cloarec, R. Sneppe, E. Schräm and J.V. Fenollar, Glucose and erythrocyte ATP: distinctive effects of dipyridamole and of ticlopidine, Angiology 38 (1987), 815-823.
12. J. Conard, C. Lecrubier, P.Y. Scarabin, M.H. Horellou, M. Samama and M.G. Bousser, Effects of long term administration of ticlopidine on platelet function and haemostatic variables, Thromb. Res. 20 (1980), 143-148.
13. J. Harkness, The viscosity of human blood plasma; its measurement in health and disease, Biorheology 8 ( 1971 ), 171-193.
14. J. Mikita, G. Nash and J. Dormandy, A simple method of preparing white blood cells for filterability testing, Clin. Hemorheol. 6 (1986), 635-639.
15. International Committee for Standardization in Haematology (Expert Panel on Blood Rheology), Guidelines on selection of laboratory tests for monitoring the acute phase response, J. Clin. Palhol. 41 (1988), 1203-1212.
16. M.A. Lichtman, J. Heal and J.M. Rowe, Hyperleukocytic leukaemia: rheological and clinical features and management, Bailliere's Clin. Haematol. 1 (1987), 725-746.
17. M.J. Quinn and D.J. Fitzgerald, Ticlopidine and clopidogrel, Circulation 12 (1999), 1667-1672.
18. [ 18] M.S. Brown and J.L. Goldstein, The hyperlipoproteinemias and other disorders of lipid metabolism, in: Harrison 's Principles of Internal Medicine, K.I. Braunwald, R.G. Isselbaker, J.D. Petesdorf, J.B.M. Wilson and A.S. Fauci, eds, McGraw-Hill, New York, 1987, pp. 1650-1661.
19. [ 19] M.W. Kenny, M. Meakir and J. Stuart, Measurement of erythrocyte filterability using washed-erythrocyte and whole blood methods, Clin. Haemrheol. 1 (1981), 135-146.
20. R. Salesse, J. Gamier and D. Daveloose, Modulation of adenylate cyclase activity by the physical state of pigeon erythrocyte membrane. 2. Fluidity-controlled coupling between the subunits of the adenylate cyclase system, Biochemistry 21 (1982), 1587-1590.
21. R.W. Colman, J. Kuchibhotla, M.K. Jain and R.K. Murray, Phase separation in phosphatidylcoline bilayers as a predictor of inhibition of blood platelet aggregation by amantadines, Biochim. Biophys. Acta 467 (1977), 273-279.
22. S. Chien, Principles and tecniques for assessing erythrocyte deformability, Blood Cells 3 (1978), 71-74.
23. S.E. Lennie, G.D.O. Lowe, J.C. Barbenel, C.D. Forbes and W.S. Foulds, Filterability of white blood cell subpopulations, separated by an improved method, Clin. Haemorheol. 7 (1987), 811-816.
24. S.J. Shattil and R.A. Cooper, Membrane microviscosity and human platelet function, Biochemistry 15 (1976), 4832-4837.
25. S. Kinlay and P. Ganz, Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy, Am. J. Cardiol. 86 (2000), 10-13.
26. W.E. Connor and S.L. Connor, The dietary treatment of hyperlipidemiae: rationale, tecnique and efficacy, Med. Clin. North Am. 66 ( 1982), 485-518.